Organized by
Human Resource Strategy Center for Global Health,National Center for Global Health and Medicine

Workshop on Advisory mechanisms
in International Organizations:
Quest for Expert Contribution to Global Health
国際機関規範設定メカニズムワークショップ～専門家として国際貢献する道～
Venue: Tokyo Japan (Zoom)
PROGRAMPROGRAM
DATE
15：00-15：30 Opening
Dr Nakatani Hiroki
15：30-15：45 Overview of WHO advisory groups
Dr John Grove
15：45-16：45 Examples of WHO advisory groups:
the perspectives of WHO and the members
Dr Sabine Kopp
Dr Sato Daisaku
Dr Yamamoto Naoko
16：45-17：00 Tea Break
17：00-18：00 Example of works in Policy andScientific Advisory Bodies 2. Global Fund
Dr Komatsu Ryuichi
Dr Nagai Mari
18：00-18：20 Summing Up
18：20-18:30 Closing*JST （UTC +09:00）

2nd Oct. 2020Friday
15:00～18:30
内 容
国際機関の専門家委員会への参加を希望する
日本人専門家を対象に、専門家委員会に求められる人材、そのリクルートメントプロセスなどを、採用する国際機関、実際に専門家委員会に参加されている方などからわかりやすくお話いただきます対 象 者

Language: English
Mode: Hybrid Meeting (live meeting with limited numberof “ in persons” + virtual meetings )* Please keep in mind this schedule is subject to change

WHO協力センター、医療機関、大学、企業、研究機関、NGO等ですでに高い専門分野を持ち、今後、国際機関にて国際的なルール作りに参画したい方※本ワークショップは厚生労働省の委託により邦人職員の増強を目的としているため、日本国籍以外の方のご参加はご遠慮頂いています。

■ Please apply through...
下記URLもしくはQRコードから申し込みフォームへアクセスいただき、必要事項をご入力ください。

https://pro.form-mailer.jp/fms/47e673fb204264

Registration deadline： 29th September 2020

申し込みフォームQRコードはこちら

Enquiry: Human Resource Strategy Center for Global Health, National Center for Global Health and Medicine(NCGM)
TEL: 03-6228-0496 MAIL: hrcgh10@gmail.com
For Registration: TEL: 03-5956-3057 MAIL: hrc-gh@tabikobo.com (C/O Tabikobo Co.,LTD)

Speakers

Dr. Hiroki Nakatani
Dr. Hiroki Nakatani is presently, Project Professor, Global Research Institute at Keio University and Invited Professor atOsaka University Post Graduate School of Medicine. Also, Member, Executive Board, WHO; Chair, Board of Directors,Global Health Innovative Technology Fund (GHIT Fund); Project Director, Hub on Population Ageing, Association ofPacific Rim Universities( APRU); Member, Board of Directors, National Center for Global Health and Medicine; andDirector, Human Resource Strategy Center for Global Health with grant from the Ministry.
He served as Assistant Director-General of WHO from March 2007 to May 2015. He led the largest technical clustercomprising HIV/AIDS, Tuberculosis, Malaria and Neglected Tropical Diseases. During his tenure, the morbidity andmortality of these three major infections showed trends of decline, and a few tropical diseases were on track towards
elimination and even eradication in case of dracunculiasis (guinea worm disease).
Before joining WHO, he worked at the Ministry of Health, Labour and Welfare of Japan. Dr. Nakatani received his M.D.
from Keio University School of Medicine, M.H.P.Ed from the University of New South Wales, and Ph.D. from Keio
University.

Dr. John Grove
Dr. John Grove became the first director of Quality Assurance for Norms & Standards (QNS) on July 1, 2019 at WHO,Headquarters in the new Science Division announced in March 2019. He is establishing and leading functions andassurance services for all WHO global norms and standards products, and oversees the WHO Press, and WHO Global
Library and Digital Information Services. Prior, he was director of the Department of Information, Evidence andResearch (IER), overseeing global health statistics, monitoring and evaluation, applied ethics, research coordination,and guidelines development. He joined WHO on 1 September 2017.
Before joining WHO, Dr. Grove was Deputy Director for Evidence and Policy in the MNCH team at the Bill and Melinda
Gates Foundation (BMGF). He was responsible for the investment portfolio on evidence and research and also worked
within the organization to set strategy and guide related health analytics, in addition to being a representative on
evidence and policy with the foundation’s external partners, including the UN system. He also served on the global
health strategy team in the Office of the President and worked across HIV, TB, pneumonia, diarrhea, and immunization
teams on strategy development and evaluation.
Prior to BMGF, Dr. Grove was with the US Centers for Disease Control and Prevention (CDC) for 8 years in team leadand section chief roles based in Tanzania (Dar es Salaam), Zambia (Lusaka), and Cote d’Ivoire (Abidjan) supervisingdisease surveillance, program monitoring and evaluation, health informatics, nurse, lab, and medical training programs,
and as a lead US diplomat with host country governments on technical assistance and resource negotiation.
Past affiliations include director and analyst roles at the Public Health Institute (Berkeley, CA), the David and Lucile
Packard Foundation (Los Altos, CA), the Futures Group International (Wash., DC) and consulting for the County of Los
Angeles Department of Public Health Services. He holds a PhD in health services research from the Royal Melbourne
Institute of Technology, a Masters in applied anthropology from the University of San Francisco, and a Bachelors’ inInternational Relations from Kent State University.
He has authored several peer reviewed articles, book chapters, and reviews.

Speakers

Dr. Sabine Kopp
Dr. Sabine Kopp is the Lead of the World Health Organization’s (WHO) Norms and Standards for Pharmaceuticals Team.
Among the various positions she held in WHO she was Secretary for the International Nonproprietary Names (INN)
Programme, Acting Team Coordinator for Quality Assurance and Safety of Medicines, Lead of the Medicines Quality
Assurance Group, Programme Manager for the Quality Assurance and the Anticounterfeiting programmes, Acting
Secretary of the International Medical Products Anti-Counterfeiting Taskforce (IMPACT) and was also actively involvedin the WHO Member State mechanism on Substandard/spurious/falsely-labelled/falsified/counterfeit medical products.
Sabine Kopp is Secretary of the WHO Expert Committee on Specifications for Pharmaceutical Preparations and is
responsible for the coordination of WHO's activities related to the development and maintenance of internationalguidelines, GXPs, standards and norms related to Medicines Quality Assurance and the International Pharmacopoeia,
i.e. the normative work related to Medicines Quality Assurance within WHO, spanning from development andmanufacturing to the distribution and supply of the medicines, as well as regulatory guidance such as stability
requirements and interchangeability of multisource medicines. She is overseeing WHO’s External Quality Assurance
Assessment Scheme for quality control laboratories, serving as Secretary the international meetings of world
pharmacopoeias and involved in WHO activities aimed at enabling synergies and convergence in medicines quality
assurance globally.

Dr. Daisaku Sato
Dr. Daisaku Sato is Chief Management Officer / Associate Centre Director for Regulatory Science, Pharmaceuticals andMedical Devices Agency (PMDA).
From June 2016 to July 2018, he was Director, Pharmaceutical Safety Division, Pharmaceutical Safety andEnvironmental Health Bureau, the Ministry of Health, Labour and Welfare (MHLW), Japan.
Before back to MHLW, from 2013 to 2016, he was Director, Office of New Drug V for oncology drug review and Director,
Office of Cellular and Tissue based Products at PMDA, respectively.
From 2011 to 2013 he was Director, Office of Compliance, Pharmaceutical and Food Safety Bureau, MHLW and involvedin the quality assurance of medicines and global issues of spurious & falsified (SF) drugs.
Dr Sato worked for more than 25 years as a technical administrator at MHLW, Japan. He also experienced various drug
regulatory responsibilities in pharmacovigilance, clinical research, health research funding, blood safety, food safety,international harmonisation (such as ICH) and normative activities at MHLW. During his service of the Ministry, heworked at Division of Drug Management and Policy, WHO (Geneva) on secondment from 1994 to 1996.
He is a registered pharmacist and was received Ph.D. degree (pharmaceutical sciences) from the University of Tokyo.
He has been a member of the WHO Expert Advisory Panel on the International Pharmacopoeia and PharmaceuticalPreparations since 2015.

Speakers

Dr. Naoko Yamamoto
Dr. Naoko Yamamoto was most recently WHO's Assistant Director-General for Universal Health Coverage and Health
Systems. Dr. Yamamoto brings nearly 30 years of experience working on health in Japan and served as Senior AssistantMinister for Global Heath in Japan’s Ministry of Health, Labour and Welfare. In this capacity, she was heavily involved
in Japan’s global health leadership, including hosting and organizing the International Conference on Universal Health
Coverage in 2015 and supporting the compilation of the G7 Ise-Shima Vision for Global Health and Kobe Communiqueof the G7 Health Ministers’ Meeting in 2016, both of which highlighted the importance of promoting universal healthcoverage.
Prior to this role, she served in numerous health-related positions within the government of Japan, including as
Director General of the Hokkaido Regional Bureau of Health and Welfare, Director of the Health and Medical Divisionat the Ministry of Defense, and Counsellor to the Permanent Mission of Japan to the United Nations. She holds a
medical degree, a PhD in epidemiology and a Masters in Public Health.

Dr. Ryuichi Komatsu
Dr. Ryuichi Komatsu is a Senior Adviser at the Global Fund, responsible for the Technical Evaluation Reference Group(TERG) Secretariat. He has revitalized the role and contribution of the TERG. Before this, he developed and establishedthe results system and strategic information function of the Global Fund. Prior to working at the Global Fund, he has
worked with governments, NGOs, academia, and UN agencies.

Dr. Mari Nagai
Dr. Mari Nagai has over 20 years of experience in global health in Pacific, Asia, Middle East and African countries. Her
areas of expertise are in health system strengthening and reproductive, maternal and newborn health.
Her career of global health started as a medical doctor of MSF (Doctors Without Borders) to provide humanitarianassistance for populations displaced by conflict. Later she began working as a public health practitioner with a variety ofacademic, non-government organizations, bilateral and UN organizations.
She has conducted research concerning the health system reconstruction process in post-conflict countries. She
actively supported the Department of Human Resources in Ministry of Health in Francophone African countries toidentify the determining factors for the retention of qualified health workforce in rural areas, and develop feasible
policy that Ministries could implement. During her time at the WHO Western Pacific Regional Office as a Medical Officer,
she worked extensively to improve the quality of reproductive, maternity and newborn care in the Pacific and Asiancountries.
In addition to earning a medical degree then a fellow of the internal medicine in Japan, she received an MPH fromJohns Hopkins School of Public Health and a PhD at the Nagoya University Graduate School of Medicine. She served in
the Global Fund Technical Review Panel from 2010-2014, and currently serving in the Global Fund Technical Evaluation
Reference Group as an expert of health system.